Health
CRISPR-Cas9 Editing Can Favor Cancer-Linked KRAS Genes – Clinical OMICs News
Clinical trials based on CRISPR technology have been deferred due to potential risks, such as off-target effects, the creation…
Highlighting the need to monitor patients who have undergone CRISPR-Cas9-based gene therapy for cancer-related mutations, researchers at Sanford Burnham Prebys have shown that gene editing, specifically gene knockout (KO) using CRISPR-Cas9 technology, can…
Continue Reading
-
Noosa News21 hours agoDisaster relief packages announced for flood-stricken western Queensland
-
Noosa News24 hours agoHow to get the most from potted citrus and when they’ll fruit
-
General23 hours agoPeter Dutton partially walks back public service work-from-home vow
-
General23 hours agoWhy was Trump the first to address the ideological battle in universities?